The study is sponsored by the Division of AIDS (DAIDS) of the National Institutes of Health (NIH) through a grant to the Gladstone Institutes in San Francisco California. Gilead Sciences donates drug for iPrEx OLE, but does not contribute financially to the study and does not participate in its design, conduct or data analysis.

| Lima | |
| Iquitos | |
| Guayaquil | |
| San Francisco | |
| Boston | |
| Chicago | |
| São Paulo | |
| Rio de Janeiro | |
| Chiang Mai | |
| Cape Town |